Categories: All postsAnalysts

Cematrix. Buy, Sell or Hold?

Cematrix (Cematrix Stock Quote, Chart, News, Analysts, Financials TSXV:CEMX) will release its Q3 results on Nov. 5 after market close, with a conference call and webinar scheduled for Nov. 6 at 1 p.m. EST. Beacon Securities analyst Russell Stanley, who maintains a “Buy” rating and $0.55 target, said he expects a seasonally strong quarter supported by execution on large U.S. infrastructure projects.

Stanley reiterated on Oct. 3 that Q3 is “typically the strongest quarter of the year,” and he is looking for revenue of $16.0-million and Adjusted EBITDA of $2.1-million.

His forecast assumes sequential revenue growth of 50%, though he anticipates margins will moderate as project mix shifts. He noted that Q2 benefited from “a number of smaller, higher-margin projects.”

In contrast, Q3 reflects work that began in June on a major U.S. Midwest tunnel-grouting project and, starting in July, on the $22-million North Carolina project, which together provide a steadier revenue base over the next 12 months. Stanley expects gross margins to normalize to 25% in Q3 and is looking for $1.8-million in operating cash flow before working-capital changes.

Cematrix manufactures cellular concrete for infrastructure, industrial, and commercial construction projects across the U.S. and Canada. The Calgary-based company also has key offices in Chicago and Bellingham, Washington.

Stanley said he will be watching for a backlog update with the Q3 release. Cematrix exited Q2 with a $76-million backlog, and subsequent contract announcements have brought year-to-date awards to $44-million. As large-project execution ramps, Stanley expects the backlog to trend closer to a more typical 1.0x revenue versus 1.6x at June 30.

He also noted that the stock recently reached new 52-week highs and is trading at 5.6× his F2026 Adjusted EBITDA forecast, a 39%–41% discount to the 9.1–9.5× average among infrastructure, engineering, and cement producer peers.

Stanley said Cematrix should generate $6-million in Adjusted EBITDA on $49-million of revenue in fiscal 2025, improving to $10-million on $67-million in fiscal 2026.

-30-

Tagged with: CEMX
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Buy Graham Corporation on the pullback, analyst says

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and $130.00 target on Graham Corporation (Graham Corporation Stock Quote, Chart,… [Read More]

7 hours ago

iFabric is just getting started, this analyst says

Beacon Securities analyst Doug Cooper says iFabric’s (iFabric Stock Quote, Chart, News, Analysts, Financials TSX:IFA) medical scrubs opportunity is being… [Read More]

8 hours ago

MDA Space stock is a double from here, analyst says

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and street-high $88.00 target on MDA Space (MDA Space Stock Quote,… [Read More]

11 hours ago

Can Hammond Power stock go even higher?

National Bank Financial analyst Baltej Sidhu raised his target on Hammond Power Solutions (Hammond Power Solutions Stock Quote, Chart, News,… [Read More]

12 hours ago

What’s going on with Canada’s job losses?

RBC senior economist Claire Fan says Canada’s September job losses were concentrated among younger workers and should not be overread.… [Read More]

14 hours ago

This biotech stock has a massive upside, Roth says

Roth Capital Partners analyst Adam Walsh says a third controlled celiac disease dataset supporting IL-15 blockade increases the potential value… [Read More]

14 hours ago